Skip to main content
. Author manuscript; available in PMC: 2009 Jul 23.
Published in final edited form as: AJR Am J Roentgenol. 2009 Jul;193(1):157–164. doi: 10.2214/AJR.08.2051

Table 1. Performance Measures and Definitions Included in the Basic Clinical Relevant Mammography Audit of the American College of Radiology.

Performance Measure Definition

Recall rate Percentage of screening examinations recommended for additional imaging (BI-RADS category 0)
Abnormal interpretation rate Percentage of screening examinations interpreted as positive (BI-RADS categories 0, 4, and 5)
Recommendation for biopsy or surgical consultation Number of recommendations for biopsy or surgical consultation (BI-RADS categories 4 and 5)
Known false-negatives Diagnosis of cancer within 1 year of a negative mammogram (BI-RADS categories 1 or 2 for screening examination; BI-RADS categories 1, 2, or 3 for diagnostic examination)
Sensitivity Probability of detecting a cancer when a cancer exists (true-positive examinations / all examinations with cancer detected within 1 year)
Specificity Probability of interpreting an examination as negative when a cancer does not exist (true-negative examinations / all examinations without cancer detected in 1 year)
PPV1 Percentage of all positive screening examinations that result in a cancer diagnosis within 1 year
PPV2 Percentage of all screening or diagnostic examinations recommended for biopsy or surgical consultation that result in a cancer diagnosis within 1 year
PPV3 Percentage of all biopsies done after a positive screening or diagnostic examination that result in a cancer diagnosis within 1 year
Cancer detection rate Number of cancers correctly detected per 1,000 screening mammograms
Minimal cancers Percentage of all cancers that are invasive and ≤ 1 cm, or ductal carcinoma in situ
Node-negative cancers Percentage of all invasive cancers that are node negative

Note—PPV = positive predictive value.